The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination — Georgia, 2015–2016

@inproceedings{Nasrullah2017TheRO,
  title={The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination — Georgia, 2015–2016},
  author={Muazzam Nasrullah and David Sergeenko and Lia Gvinjilia and Amiran Gamkrelidze and Tengiz Tsertsvadze and Maia Butsashvili and David Metreveli and Lali Sharvadze and Maia Alkhazashvili and Shaun Shadaker and John W K Ward and Juliette Morgan and Francisco Averhoff},
  booktitle={MMWR. Morbidity and mortality weekly report},
  year={2017}
}
Georgia, a country in the Caucasus region of Eurasia, has a high prevalence of hepatitis C virus (HCV) infection. In April 2015, with technical assistance from CDC, Georgia embarked on the world's first program to eliminate hepatitis C, defined as a 90% reduction in HCV prevalence by 2020 (1,2). The country committed to identifying infected persons and linking them to care and curative antiviral therapy, which was provided free of charge through a partnership with Gilead Sciences (1,2). From… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 14 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.